Selected research
Industry Growth & Trends
Global Viral Detection Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Viral Detection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Viral Detection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Viral Detection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Viral Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Viral Detection market include Merck KGaA, Charles River Laboratories, Eurofins, SGS, Sartorius, Asahi Kasei, Samsung Biologics, Syngene and Intertek, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Viral Detection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Viral Detection market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Viral Detection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Viral Detection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Viral Detection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Viral Detection Market by Company
Merck KGaA
Charles River Laboratories
Eurofins
SGS
Sartorius
Asahi Kasei
Samsung Biologics
Syngene
Intertek
Minaris Advanced Therapies
Texcell
PathoQuest
Clean Cells
Avance Biosciences
Microbiologics
Alcami
Creative Biolabs
Creative Biogene
WuXi AppTec
WuXi Biologics
Viral Detection Segment by Type
Plaque Assays
PCR
ELISA
Others
Viral Detection Segment by Application
Blood & Blood Products
Cellular & Gene Therapy Products
Stem Cell Products
Tissue & Tissue Products
Vaccines and Therapeutics
Viral Detection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viral Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Viral Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viral Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Viral Detection companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Plaque Assays
- PCR
- ELISA
- Others
Applications
- Blood & Blood Products
- Cellular & Gene Therapy Products
- Stem Cell Products
- Tissue & Tissue Products
- Vaccines and Therapeutics
Companies covered
- Merck KGaA
- Charles River Laboratories
- Eurofins
- SGS
- Sartorius
- Asahi Kasei
- Samsung Biologics
- Syngene
- Intertek
- Minaris Advanced Therapies
- Texcell
- PathoQuest
- Clean Cells
- Avance Biosciences
- Microbiologics
- Alcami
- Creative Biolabs
- Creative Biogene
- WuXi AppTec
- WuXi Biologics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Viral Detection Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Viral Detection Market Size by Region (2021-2032)
- 1.4.1 Global Viral Detection Market Size by Region (2021-2026)
- 1.4.2 Global Viral Detection Market Size by Region (2027-2032)
- 1.5 Key Regions Viral Detection Market Size (2021-2032)
- 1.5.1 North America Viral Detection Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Viral Detection Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Viral Detection Market Size Growth Rate (2021-2032)
- 1.5.4 South America Viral Detection Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Viral Detection Market Size Growth Rate (2021-2032)
2 Viral Detection Market by Type
- 2.1 Type Introduction
- 2.1.1 Plaque Assays
- 2.1.2 PCR
- 2.1.3 ELISA
- 2.1.4 Others
- 2.2 Global Viral Detection Market Size by Type
- 2.2.1 Global Viral Detection Market Size Overview by Type (2021-2032)
- 2.2.2 Global Viral Detection Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Viral Detection Market Size Forecasted by Type (2027-2032)
- 2.3 Global Viral Detection Market Size by Regions
- 2.3.1 North America Viral Detection Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Viral Detection Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Viral Detection Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Viral Detection Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Viral Detection Market Size Breakdown by Type (2021-2026)
3 Viral Detection Market by Application
- 3.1 Type Introduction
- 3.1.1 Blood & Blood Products
- 3.1.2 Cellular & Gene Therapy Products
- 3.1.3 Stem Cell Products
- 3.1.4 Tissue & Tissue Products
- 3.1.5 Vaccines and Therapeutics
- 3.2 Global Viral Detection Market Size by Application
- 3.2.1 Global Viral Detection Market Size Overview by Application (2021-2032)
- 3.2.2 Global Viral Detection Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Viral Detection Market Size Forecasted by Application (2027-2032)
- 3.3 Global Viral Detection Market Size by Regions
- 3.3.1 North America Viral Detection Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Viral Detection Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Viral Detection Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Viral Detection Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Viral Detection Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Viral Detection Industry Trends
- 4.2 Viral Detection Industry Drivers
- 4.3 Viral Detection Industry Opportunities and Challenges
- 4.4 Viral Detection Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Viral Detection Revenue (2021-2026)
- 5.2 Global Viral Detection Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Viral Detection Key Company Headquarters & Area Served
- 5.4 Global Viral Detection Company, Product Type & Application
- 5.5 Global Viral Detection Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Viral Detection Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Viral Detection Players Market Share by Revenue in 2025
- 5.6.3 2025 Viral Detection Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Merck KGaA
- 6.1.1 Merck KGaA Company Information
- 6.1.2 Merck KGaA Business Overview
- 6.1.3 Merck KGaA Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Merck KGaA Viral Detection Product Portfolio
- 6.1.5 Merck KGaA Recent Developments
- 6.2 Charles River Laboratories
- 6.2.1 Charles River Laboratories Company Information
- 6.2.2 Charles River Laboratories Business Overview
- 6.2.3 Charles River Laboratories Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Charles River Laboratories Viral Detection Product Portfolio
- 6.2.5 Charles River Laboratories Recent Developments
- 6.3 Eurofins
- 6.3.1 Eurofins Company Information
- 6.3.2 Eurofins Business Overview
- 6.3.3 Eurofins Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Eurofins Viral Detection Product Portfolio
- 6.3.5 Eurofins Recent Developments
- 6.4 SGS
- 6.4.1 SGS Company Information
- 6.4.2 SGS Business Overview
- 6.4.3 SGS Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 SGS Viral Detection Product Portfolio
- 6.4.5 SGS Recent Developments
- 6.5 Sartorius
- 6.5.1 Sartorius Company Information
- 6.5.2 Sartorius Business Overview
- 6.5.3 Sartorius Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Sartorius Viral Detection Product Portfolio
- 6.5.5 Sartorius Recent Developments
- 6.6 Asahi Kasei
- 6.6.1 Asahi Kasei Company Information
- 6.6.2 Asahi Kasei Business Overview
- 6.6.3 Asahi Kasei Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Asahi Kasei Viral Detection Product Portfolio
- 6.6.5 Asahi Kasei Recent Developments
- 6.7 Samsung Biologics
- 6.7.1 Samsung Biologics Company Information
- 6.7.2 Samsung Biologics Business Overview
- 6.7.3 Samsung Biologics Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Samsung Biologics Viral Detection Product Portfolio
- 6.7.5 Samsung Biologics Recent Developments
- 6.8 Syngene
- 6.8.1 Syngene Company Information
- 6.8.2 Syngene Business Overview
- 6.8.3 Syngene Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Syngene Viral Detection Product Portfolio
- 6.8.5 Syngene Recent Developments
- 6.9 Intertek
- 6.9.1 Intertek Company Information
- 6.9.2 Intertek Business Overview
- 6.9.3 Intertek Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Intertek Viral Detection Product Portfolio
- 6.9.5 Intertek Recent Developments
- 6.10 Minaris Advanced Therapies
- 6.10.1 Minaris Advanced Therapies Company Information
- 6.10.2 Minaris Advanced Therapies Business Overview
- 6.10.3 Minaris Advanced Therapies Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Minaris Advanced Therapies Viral Detection Product Portfolio
- 6.10.5 Minaris Advanced Therapies Recent Developments
- 6.11 Texcell
- 6.11.1 Texcell Company Information
- 6.11.2 Texcell Business Overview
- 6.11.3 Texcell Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Texcell Viral Detection Product Portfolio
- 6.11.5 Texcell Recent Developments
- 6.12 PathoQuest
- 6.12.1 PathoQuest Company Information
- 6.12.2 PathoQuest Business Overview
- 6.12.3 PathoQuest Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 PathoQuest Viral Detection Product Portfolio
- 6.12.5 PathoQuest Recent Developments
- 6.13 Clean Cells
- 6.13.1 Clean Cells Company Information
- 6.13.2 Clean Cells Business Overview
- 6.13.3 Clean Cells Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Clean Cells Viral Detection Product Portfolio
- 6.13.5 Clean Cells Recent Developments
- 6.14 Avance Biosciences
- 6.14.1 Avance Biosciences Company Information
- 6.14.2 Avance Biosciences Business Overview
- 6.14.3 Avance Biosciences Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Avance Biosciences Viral Detection Product Portfolio
- 6.14.5 Avance Biosciences Recent Developments
- 6.15 Microbiologics
- 6.15.1 Microbiologics Company Information
- 6.15.2 Microbiologics Business Overview
- 6.15.3 Microbiologics Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Microbiologics Viral Detection Product Portfolio
- 6.15.5 Microbiologics Recent Developments
- 6.16 Alcami
- 6.16.1 Alcami Company Information
- 6.16.2 Alcami Business Overview
- 6.16.3 Alcami Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Alcami Viral Detection Product Portfolio
- 6.16.5 Alcami Recent Developments
- 6.17 Creative Biolabs
- 6.17.1 Creative Biolabs Company Information
- 6.17.2 Creative Biolabs Business Overview
- 6.17.3 Creative Biolabs Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Creative Biolabs Viral Detection Product Portfolio
- 6.17.5 Creative Biolabs Recent Developments
- 6.18 Creative Biogene
- 6.18.1 Creative Biogene Company Information
- 6.18.2 Creative Biogene Business Overview
- 6.18.3 Creative Biogene Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Creative Biogene Viral Detection Product Portfolio
- 6.18.5 Creative Biogene Recent Developments
- 6.19 WuXi AppTec
- 6.19.1 WuXi AppTec Company Information
- 6.19.2 WuXi AppTec Business Overview
- 6.19.3 WuXi AppTec Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 WuXi AppTec Viral Detection Product Portfolio
- 6.19.5 WuXi AppTec Recent Developments
- 6.20 WuXi Biologics
- 6.20.1 WuXi Biologics Company Information
- 6.20.2 WuXi Biologics Business Overview
- 6.20.3 WuXi Biologics Viral Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 WuXi Biologics Viral Detection Product Portfolio
- 6.20.5 WuXi Biologics Recent Developments
7 North America
- 7.1 North America Viral Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Viral Detection Market Size by Country (2021-2026)
- 7.3 North America Viral Detection Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Viral Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Viral Detection Market Size by Country (2021-2026)
- 8.3 Europe Viral Detection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Viral Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Viral Detection Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Viral Detection Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Viral Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Viral Detection Market Size by Country (2021-2026)
- 10.3 South America Viral Detection Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Viral Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Viral Detection Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Viral Detection Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst